First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study

Combination chemotherapy with capecitabine and oxaliplatin for gastric cancer (G-XELOX) is considered as a potentially promising regimen. However, the use of the G-XELOX regimen in Japanese patients has not been investigated to date, and recommended doses of G-XELOX for Japanese patients with metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Satake, Hironaga, Yasui, Hisateru, Kotake, Takeshi, Okita, Yoshihiro, Hatachi, Yukimasa, Kotaka, Masahito, Kato, Takeshi, Tsuji, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582530/
https://www.ncbi.nlm.nih.gov/pubmed/28894576
http://dx.doi.org/10.3892/mco.2017.1335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582530/
https://www.ncbi.nlm.nih.gov/pubmed/28894576
http://dx.doi.org/10.3892/mco.2017.1335

Ejemplares similares